Aura Biosciences, Inc. (AURA) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19
	10-K	8-K	10-K	8-K	10-K	S-1/A
Revenues	0.0	42.2	0.0	25.2	0.0	0.0
Revenue growth		67.9%
Cost of goods sold	-120.3	0.0	0.0	0.0	0.0	0.0
Gross profit	120.3	42.2	0.0	25.2	0.0	0.0
Gross margin	-1336255.6%	100.0%		100.0%
Selling, general and administrative [+]	18.1	18.1	10.1	10.1	4.2	4.5
General and administrative	18.1	18.1	10.1	10.1	4.2	4.5
Research and development	42.2		25.2		18.0	19.6
Other operating expenses	120.6	85.1		50.3		0.0
EBITDA [+]	-59.4		-34.4		-21.4	-23.6
EBITDA growth	72.7%	72.9%	61.0%		-9.6%
EBITDA margin	660400.0%	-144.3%		-140.1%
Depreciation and amortization	1.2		0.8		0.8	0.5
EBIT [+]	-60.6	-60.9	-35.3	-35.3	-22.2	-24.2
EBIT growth	71.9%	72.9%	58.8%		-8.1%
EBIT margin	673477.8%	-144.3%		-140.1%
Non-recurring items [+]	-0.3	-0.3	0.0	0.0		0.0
Loss (gain) on sale of assets	-0.3	-0.3	0.0	0.0		0.0
Interest income		1.9		0.0
Interest income		1.9		0.0
Other income (expense), net [+]	1.5	0.0	0.0	0.0		24.1
Unrealized gain/loss on derivatives					0.0
Change in fair value of warrants					0.0
Other	0.0	0.0		0.0
Pre-tax income	-58.8	-58.8	-35.3	-35.3	-22.2	0.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-58.8	-58.8	-35.3	-35.3	-22.2	0.0
Net margin	652922.2%	-139.1%		-140.1%

Basic EPS [+]	($1.96)	$0.00	($6.83)	($0.01)	($60.47)	$0.00
Growth	-71.3%	-71.3%	-88.7%
Diluted EPS [+]	($1.96)	$0.00	($6.83)	($0.01)	($60.47)	$0.00
Growth	-71.3%	-71.3%	-88.7%

Shares outstanding (basic) [+]	29.9	29,937.2	5.2	5,160.0	0.4	338.3
Growth	480.2%	480.2%	1305.2%		-99.9%
Shares outstanding (diluted) [+]	29.9	29,937.2	5.2	5,160.0	0.4	338.3
Growth	480.2%	480.2%	1305.2%		-99.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.